|
|
Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of their key products in agrochemical segment which are generally used in crop protection and Dicap is one of the key Pharmaceutical intermediate which is used in manufacture of antifungal agents.
Astec has multipurpose production facilities at 2 locations.
1. Dombivli - 1 plant (50km from Mumbai)
2. Mahad - 2 plants ( 180 kms from Mumbai)
Astec started it's first manufacturing unit in August 1994 in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap. In the year of 2002, Astec entered into an agreement with Behram Chemicals Private Limited for using and operating their manufacturing facilities located at Mahad Industrial Area, Maharashtra. During 2003-04 company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT.
Astec has been granted ISO 9001:2000 Certificate of Assessment by International Standards Certification Pvt limited, Australia for “Design, Development, Manufacture and Supply of Organic Chemical and Intermediates for Pharmaceutical and Agrochemical Industry”.
Astec LifeSciences is promoted by 2 entrepreneurs:
1. Mr. Ashok Hiremath - aged 54 years, is a Masters of Arts from University of Oxford and Post Graduate Diploma holder in Chemical Engineering from University College, University of London.
2. Dr. P.L. Tiwari - aged 64 years, is a MBBS and MD (Medicine) from Banaras Hindu University. He is a Member of the Royal College of Physicians of the United Kingdom (MRCP) and Fellow of Royal College of Physicians, Edinburgh (FRCP). He is a practicing cardiologist in Mumbai. He was awarded UP Ratna award in January, 1996 by the Chief Minister of Maharashtra. He was also awarded L U Kirpalani Memorial Award for Life Time Achievement- 2005 by A’ward Medical Association.
The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital:
1. Expansion of our existing manufacturing facilities at Mahad, Maharashtra;
2. Expansion of our existing Research and Development facility at Dombivli, Maharashtra;
3. Meeting Registration expenses;
4. Meeting long-term working capital requirements;
5. General Corporate Purposes;
6. Issue Expenses.
| IPO Opening Date | Oct 29, 2009 |
| IPO Closing Date | Nov 4, 2009 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹77 to ₹82 per equity share |
| Market Lot | 75 Shares |
| Min Order Quantity | 75 Shares |
| Listing At | BSE, NSE |
| Issue Size | 7,500,000 Eq Shares of ₹10 (aggregating up to ₹61.50 Cr) |
The Astec IPO market lot size is 75 shares. A retail-individual investor can apply for up to 32 lots (2400 shares or ₹196,800).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 75 | ₹6,150 |
| Maximum | 32 | 2400 | ₹196,800 |
CARE has assigned an IPO Grade 2 to Astec LifeSciences Limited IPO. This means as per CARE, company has below average fundamentals. CARE assigns IPO gradings on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Link to download CARE rating document.
The Astec IPO is subscribed 1.56 times on Nov 4, 2009 17:00. The public issue subscribed 2.36 in the retail category, 0.61 in the QIB category, and 3.00 in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 0.61 |
| NII | 3.00 |
| RII | 2.36 |
| Employee | 0.50 |
| Total | 1.56 |
| Listing Date | Wednesday, November 25, 2009 |
| BSE Script Code | 533138 |
| NSE Symbol | ASTEC |
| Listing In | B Group of Securities |
| ISIN | INE563J01010 |
| IPO Price | ₹82 per equity share |
| Face Value | ₹10 per equity share |
|
|
|
Astec LifeSciences Limited
5-5A, 4th floor,
Kamanwala Chambers, Sir P. M. Road,
Fort, Mumbai - 400001
Phone: +91-22-2261 8212-13
Email: ipo@astecls.com
Website: http://www.astecls.com
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com
Sorry, we couldn't find any reviews, please check back later.
Astec IPO is a main-board IPO of 7,500,000 equity shares of the face value of ₹10 aggregating up to ₹61.50 Crores. The issue is priced at ₹77 to ₹82 per equity share. The minimum order quantity is 75 Shares.
The IPO opens on Oct 29, 2009, and closes on Nov 4, 2009.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Astec IPO opens on Oct 29, 2009 and closes on Nov 4, 2009.
Astec IPO lot size is 75 Shares and the minimum order quantity is 75 Shares.
You can apply in Astec IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Astec IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Astec IPO allotment status.
Useful Articles
Rs 0 Eq Delivery Brokerage
Flat ₹10 Per Trade in F&O
Rs 0 Demat AMC
